Today, most countries have officially determined that most kids don’t need COVID shots. But in the U.S., the CDC still recommends COVID vaccinations for babies and children six months and older. I found that American doctors are sometimes given a […]
The following is an excerpt from The Vaccine Reaction. The number of lawsuits filed in North Carolina against Merck for its HPV (human papillomavirus) vaccine, Gardasil, continue to mount and allege the company did not prove the vaccine was safe
The pharmaceutical industry has long claimed that the government trying to negotiate better prices for Medicare, health are for the elderly, takes away from new drug research and development. But a new report by the watchdog group Public Citizen and Protect our Care reveals
The following is a news analysis. The following is an excerpt from The Vaccine Reaction. Medical schools in the U.S. may face direct pressure from pharmaceutical companies should they question certain drugs. A Merck employee said that he personally called
The following is an excerpt from Bloomberg News. Merck & Co.’s Covid-19 pill is giving rise to new mutations of the virus in some patients, according to a study that underscores the risk of trying to intentionally alter the pathogen’s
(STUDY) Merck’s Covid pill linked to creation of new Covid mutations Read More »
The following is an excerpt from Becker’s Hospital Review. Moderna and Merck entered an agreement Oct. 12 to develop, manufacture and sell personalized cancer vaccine candidates. The two drugmakers have been collaborators since 2016, but under the amended agreement, Merck will pay
Moderna, Merck join forces to develop cancer vaccine Read More »
Informed Consent Action Network (ICAN) has obtained a White House email showing that Facebook, Merck, and the Centers for Disease Control (CDC) Foundation, whose corporate partners includes Pfizer, have formed an alliance “to use social media and digital platforms to
Below is an excerpt from Medpage Today. With the release of updated data, oral antiviral molnupiravir to treat high-risk COVID-19 showed only a 30% reduction in the risk of hospitalization and death, according to briefing documents from FDA staff. The
(READ) Review shows Merck’s newly-approved pill for Covid-19, only 30% effective Read More »
